#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	1196	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1212	53.0	0	.	p	.	0	K29T	NONSYN	85	87	AAG	358	360	ACG	72;70;68	A;C;G	72;70;67	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	4262	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.2	1372	153.0	0	.	p	.	0	G394S	NONSYN	1180	1182	GGC	1179	1181	AGC	76;77;76	A,G;G;C	51,25;77;76	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	4262	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.2	1372	153.0	1	SNP	p	L121Q	0	.	.	361	363	CTG	360	362	CTG	179;183;180	C;T;G,C	178;182;179,1	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:L121Q:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	4262	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.2	1372	153.0	1	SNP	p	Q125R	0	.	.	373	375	CAG	372	374	CAG	184;189;189	C;A;G	183;184;188	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125R:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	4262	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.2	1372	153.0	1	SNP	p	Q125K	0	.	.	373	375	CAG	372	374	CAG	184;189;189	C;A;G	183;184;188	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	4262	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.2	1372	153.0	1	SNP	p	Q125E	0	.	.	373	375	CAG	372	374	CAG	184;189;189	C;A;G	183;184;188	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125E:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	4262	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.2	1372	153.0	1	SNP	p	Y161N	0	.	.	481	483	TAC	480	482	TAC	195;194;198	T;A;C	195;193;198	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161N:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	4262	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.2	1372	153.0	1	SNP	p	Y161D	0	.	.	481	483	TAC	480	482	TAC	195;194;198	T;A;C	195;193;198	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	4262	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.2	1372	153.0	1	SNP	p	Y161C	0	.	.	481	483	TAC	480	482	TAC	195;194;198	T;A;C	195;193;198	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	4262	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.2	1372	153.0	1	SNP	p	G317D	0	.	.	949	951	GGC	948	950	GGC	191;191;171	G;G;C,A	188;189;95,75	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:G317D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	4262	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.2	1372	153.0	1	SNP	p	A376V	0	.	.	1126	1128	GCA	1125	1127	GCA	172;169;169	G,GA;C;A	164,1;164;167	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	4262	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.2	1372	153.0	1	SNP	p	A376S	0	.	.	1126	1128	GCA	1125	1127	GCA	172;169;169	G,GA;C;A	164,1;164;167	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	4262	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.2	1372	153.0	1	SNP	p	E379K	0	.	.	1135	1137	GAA	1134	1136	GAA	171;172;173	G;A;A	170;172;173	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	4262	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.2	1372	153.0	0	HET	.	.	.	T135C	.	135	135	T	134	134	T	109	T,C	78,29	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	4262	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.2	1372	153.0	0	HET	.	.	.	C216T	.	216	216	C	215	215	C	150	C,T	86,61	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1904	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c4.ctg.1	1911	53.5	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1663	1665	AAA	36;37;36	A;A;A	36;37;36	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	2412	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c4.ctg.1	1882	68.9	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1294	1296	GAA	91;93;97	G;A;A	91;92;96	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	580	H_NS	414	414	99.03	H_NS.l15.c4.ctg.1	896	34.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	269	G	268	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	270	C	269	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	232	C	231	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	298	T	296	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	335	C	334	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	231	C	230	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	240	A	239	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	243	A	243	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	240	A	239	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	214	T	211	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	210	C	208	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	203	C	202	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	203	A	203	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	221	G	220	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	225	C	224	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	236	T	236	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	280	G	280	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	307	G	307	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	314	T	313	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	277	T	274	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	260	G	258	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	218	C	218	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	209	A	206	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	192	C	190	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	191	C	189	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	95	A	95	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	93	A	93	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	88	G	88	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	81	C	81	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	155	T	155	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	173	G	173	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	142	T,C	141,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	6942	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	785	214.9	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	371	C	370	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1808	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1680	57.8	0	.	p	.	0	H2R	NONSYN	4	6	CAT	338	340	CGT	59;61;61	C;G;T	59;60;61	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1808	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1680	57.8	0	.	p	.	0	V30I	NONSYN	88	90	GTC	422	424	ATC	75;75;76	A;T;C	74;75;76	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1808	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1680	57.8	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1181	1183	GGC	62;61;64	G;G;C	62;61;63	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2644	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2139	66.4	0	.	p	.	0	R8S	NONSYN	22	24	AGA	312	314	AGC	32;33;36	A;G;C	31;33;36	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2644	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2139	66.4	0	.	p	.	0	I142L	NONSYN	424	426	ATA	714	716	CTA	59;58;59	C;T;A	59;58;59	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2644	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2139	66.4	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1233	1235	CAA	94;97;96	C;A;A	94;97;96	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2644	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2139	66.4	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1332	1334	GGT	60;60;60	G;G;T	58;60;60	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2644	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2139	66.4	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1902	1904	GTT	54;53;53	G;T;T	54;52;53	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1036	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1832	30.4	0	.	p	.	0	A125E	NONSYN	373	375	GCA	710	712	GAA	45;46;46	G;A;A	45;46;46	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1036	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1832	30.4	0	.	p	.	0	M185T	NONSYN	553	555	ATG	890	892	ACC	18;17;17	A;C;C	18;16;16	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1036	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1832	30.4	0	.	p	.	0	S225T	NONSYN	673	675	TCC	1010	1012	ACT	24;23;23	A;C;T	24;23;23	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1036	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1832	30.4	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1400	1402	ATC	22;23;25	A;T;C	22;23;25	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	1458	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1593	49.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	1570	aad-	789	789	100.0	aad-.l6.c30.ctg.1	1408	59.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	4928	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3618	73.4	0	.	p	.	0	T85I	NONSYN	253	255	ACC	526	528	ATC	81;80;78	A;T;C	81;79;78	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	4928	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3618	73.4	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2239	2241	AAG	55;57;59	A;A;G	55;57;59	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1722	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1612	57.4	0	.	p	.	0	A22V	NONSYN	64	66	GCC	272	274	GTC	34;35;35	G;T;C	34;35;35	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1722	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1612	57.4	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1013	1015	TGC	66;65;68	T;G;C	65;65;68	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	4208	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3181	70.7	0	.	p	.	0	S46trunc	TRUNC	136	136	T	414	414	T	42	T	42	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	4208	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3181	70.7	0	.	p	.	0	G148D	NONSYN	442	444	GGC	720	722	GAC	89;89;92	G;A;C	88;88;91	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	4208	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3181	70.7	0	.	p	.	0	F240L	NONSYN	718	720	TTT	996	998	TTA	60;60;60	T;T;A	60;60;60	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	4208	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3181	70.7	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1179	1181	AAT	63;63;63	A;A;T	63;63;63	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	4208	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3181	70.7	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1966	1966	T	92	T	92	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	1096	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	1231	47.9	1	SNP	p	R45C	0	.	.	133	135	CGC	409	411	CGC	82;83;86	C;G;C	81;83;86	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	912	acrS	663	663	98.64	acrS.l6.c30.ctg.1	1235	39.8	0	.	p	.	0	L34F	NONSYN	100	102	CTC	376	378	TTC	44;43;43	T;T;C	44;43;43	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	912	acrS	663	663	98.64	acrS.l6.c30.ctg.1	1235	39.8	0	.	p	.	0	E122G	NONSYN	364	366	GAG	640	642	GGG	60;58;54	G;G;G	59;58;53	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	1436	adiY	762	762	99.61	adiY.l6.c30.ctg.1	1343	57.2	0	.	p	.	0	V136L	NONSYN	406	408	GTT	720	722	CTT	98;98;103	C;T;T	98;98;103	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	4174	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3201	70.2	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2101	2103	GCA	81;80;80	G;C;A	80;79;79	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	4174	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3201	70.2	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2362	2364	ACC	76;77;80	A;C;C	76;77;80	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	4174	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3201	70.2	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2671	2673	GCC	73;74;76	G;C;C	73;72;75	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2286	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2516	48.8	0	.	p	.	0	G37A	NONSYN	109	111	GGT	357	359	GCT	19;19;20	G;C;T	19;19;20	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2286	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2516	48.8	0	.	p	.	0	D77E	NONSYN	229	231	GAT	477	479	GAG	18;18;18	G;A;G	18;18;18	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2286	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2516	48.8	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	513	515	TGC	18;16;19	T;G;C	18;16;19	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2286	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2516	48.8	0	.	p	.	0	I150V	NONSYN	448	450	ATT	696	698	GTT	37;37;38	G;T;T	37;37;38	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2286	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2516	48.8	0	.	p	.	0	R200H	NONSYN	598	600	CGC	846	848	CAC	69;67;70	C;A;C	69;67;69	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2286	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2516	48.8	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1131	1133	ATG	78;78;78	A;T;G	78;77;78	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2286	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2516	48.8	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2127	2129	CGC	46;47;45	C;G;C	46;47;45	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	1040	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1394	39.8	0	.	p	.	0	S221T	NONSYN	661	663	AGC	1042	1044	ACC	31;30;29	A;C;C,G	31;30;28,1	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	1040	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1394	39.8	0	.	p	.	0	P225S	NONSYN	673	675	CCG	1054	1056	TCG	40;43;43	T;C;G	40;43;42	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	1014	baeR	723	723	97.79	baeR.l6.c30.ctg.1	1341	40.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1746	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	2095	44.8	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1485	1487	AAA	35;35;35	A;A;A	35;35;35	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1746	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	2095	44.8	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1497	1499	GAG	34;35;35	G;A;G	33;35;35	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1746	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	2095	44.8	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1503	1505	CAC	35;35;36	C;A;C	35;34;36	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1746	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	2095	44.8	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1557	1559	GAG	43;44;43	G;A;G	43;44;43	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	2136	cpxA	1374	1374	98.91	cpxA.l15.c30.ctg.1	1959	58.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	1240	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	1249	53.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	1282	cysB	975	975	99.28	cysB.l6.c4.ctg.1	1536	44.8	0	.	p	.	0	A146T	NONSYN	436	438	GCT	729	731	ACT	68;68;66	A;C;T	68;68;66	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	858	dfrA1_1	474	474	100.0	dfrA1_1.l15.c30.ctg.1	1070	43.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli;dfrA1
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1764	emrA	1173	1173	98.29	emrA.l15.c4.ctg.1	1759	53.9	0	.	p	.	0	I219V	NONSYN	655	657	ATC	918	920	GTC	82;81;80	G,T;T;C	79,1;76;78	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	2526	emrB	1539	1539	99.74	emrB.l15.c4.ctg.1	2137	63.5	0	.	p	.	0	E197K	NONSYN	589	591	GAA	930	932	AAA	69;67;66	A;A;A	69;67;66	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1754	emrD	1191	1191	98.4	emrD.l6.c30.ctg.1	1697	55.5	0	.	p	.	0	G209S	NONSYN	625	627	GGC	872	874	AGC	83;83;81	A;G;C	83;80;80	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	66	emrE_1	333	95	96.84	emrE_1.l6.c4.ctg.1	298	8.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1348	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1696	42.5	0	.	p	.	0	K176R	NONSYN	526	528	AAG	825	827	AGG	62;62;62	A;G;G	62;62;62	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1348	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1696	42.5	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1215	1217	GAC	35;35;34	G;A;C	35;35;34	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	962	emrR	531	531	100.0	emrR.l6.c30.ctg.1	1177	43.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	2128	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	2222	51.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	842	evgA	615	615	99.19	evgA.l15.c30.ctg.1	1229	36.7	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	457	459	CTG	58;58;59	C;T;G	58;58;58	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3840	evgS	3594	3594	97.5	evgS.l15.c17.ctg.1	4238	48.7	0	.	p	.	0	T38I	NONSYN	112	114	ACA	388	390	ATA	35;34;33	A;T;A	35;34;33	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3840	evgS	3594	3594	97.5	evgS.l15.c17.ctg.1	4238	48.7	0	.	p	.	0	L42V	NONSYN	124	126	CTA	400	402	GTA	33;32;33	G;T;A	33;32;33	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3840	evgS	3594	3594	97.5	evgS.l15.c17.ctg.1	4238	48.7	0	.	p	.	0	A93T	NONSYN	277	279	GCG	553	555	ACG	31;33;34	A;C;G	31;33;34	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3840	evgS	3594	3594	97.5	evgS.l15.c17.ctg.1	4238	48.7	0	.	p	.	0	A114E	NONSYN	340	342	GCA	616	618	GAA	46;46;44	G;A;A	46;46;44	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3840	evgS	3594	3594	97.5	evgS.l15.c17.ctg.1	4238	48.7	0	.	p	.	0	T127A	NONSYN	379	381	ACT	655	657	GCT	39;38;37	G;C;T,A	39;37;36,1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3840	evgS	3594	3594	97.5	evgS.l15.c17.ctg.1	4238	48.7	0	.	p	.	0	N133D	NONSYN	397	399	AAT	673	675	GAT	30;30;31	G;A;T	30;30;31	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3840	evgS	3594	3594	97.5	evgS.l15.c17.ctg.1	4238	48.7	0	.	p	.	0	P162S	NONSYN	484	486	CCA	760	762	TCA	37;36;34	T,A;C;A	36,1;36;34	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3840	evgS	3594	3594	97.5	evgS.l15.c17.ctg.1	4238	48.7	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	889	891	CAG	30;32;30	C;A;G	30;32;30	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3840	evgS	3594	3594	97.5	evgS.l15.c17.ctg.1	4238	48.7	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1027	1029	GTT	43;42;42	G;T;T	43;42;42	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3840	evgS	3594	3594	97.5	evgS.l15.c17.ctg.1	4238	48.7	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1183	1185	GAT	27;27;27	G;A;T	27;27;27	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3840	evgS	3594	3594	97.5	evgS.l15.c17.ctg.1	4238	48.7	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1351	1353	AAT	26;26;26	A;A;T	26;26;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3840	evgS	3594	3594	97.5	evgS.l15.c17.ctg.1	4238	48.7	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1372	1374	TTA	17;17;17	T;T;A	17;17;17	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3840	evgS	3594	3594	97.5	evgS.l15.c17.ctg.1	4238	48.7	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1573	1575	AAA	30;31;32	A;A;A	30;31;32	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3840	evgS	3594	3594	97.5	evgS.l15.c17.ctg.1	4238	48.7	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2308	2310	CAT	50;49;46	C;A;T	50;49;46	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3840	evgS	3594	3594	97.5	evgS.l15.c17.ctg.1	4238	48.7	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2362	2364	CAT	34;36;36	C;A;T	34;36;36	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3840	evgS	3594	3594	97.5	evgS.l15.c17.ctg.1	4238	48.7	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2380	2382	AGA	39;40;40	A;G;A	39;40;40	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3840	evgS	3594	3594	97.5	evgS.l15.c17.ctg.1	4238	48.7	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2395	2397	AAT	36;37;35	A;A;T	36;37;35	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3840	evgS	3594	3594	97.5	evgS.l15.c17.ctg.1	4238	48.7	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2542	2544	TCC	34;34;31	T;C;C	34;34;31	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3840	evgS	3594	3594	97.5	evgS.l15.c17.ctg.1	4238	48.7	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2707	2709	ATT	50;49;49	A;T;T	50;49;49	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3840	evgS	3594	3594	97.5	evgS.l15.c17.ctg.1	4238	48.7	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2728	2730	GAT	57;60;60	G;A;T	57;60;60	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3840	evgS	3594	3594	97.5	evgS.l15.c17.ctg.1	4238	48.7	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2842	2844	GTT	64;64;65	G;T;T	64;64;65	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3840	evgS	3594	3594	97.5	evgS.l15.c17.ctg.1	4238	48.7	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3127	3129	CAC	66;65;66	C;A;C	66;65;66	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3840	evgS	3594	3594	97.5	evgS.l15.c17.ctg.1	4238	48.7	0	.	p	.	0	M1000I	NONSYN	2998	3000	ATG	3274	3276	ATA	75;78;76	A;T;A	75;78;76	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1444	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1504	51.4	1	SNP	p	P64L	0	.	.	190	192	CCA	457	459	CCA	95;93;88	C;C;A	94;90;80	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1444	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1504	51.4	1	SNP	p	P64R	0	.	.	190	192	CCA	457	459	CCA	95;93;88	C;C;A	94;90;80	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1444	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1504	51.4	1	SNP	p	P64H	0	.	.	190	192	CCA	457	459	CCA	95;93;88	C;C;A	94;90;80	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1444	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1504	51.4	1	SNP	p	P64S	0	.	.	190	192	CCA	457	459	CCA	95;93;88	C;C;A	94;90;80	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1444	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1504	51.4	1	SNP	p	P64A	0	.	.	190	192	CCA	457	459	CCA	95;93;88	C;C;A	94;90;80	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	796	gadE	528	528	100.0	gadE.l15.c30.ctg.1	1104	38.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	238	gadW	729	729	94.24	gadW.l6.c4.ctg.1	958	13.4	0	.	p	.	0	A2T	NONSYN	4	6	GCT	59	61	ACT	2;2;2	A;C;T	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	238	gadW	729	729	94.24	gadW.l6.c4.ctg.1	958	13.4	0	.	p	.	0	V10I	NONSYN	28	30	GTT	83	85	ATT	2;2;2	A;T;T	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	238	gadW	729	729	94.24	gadW.l6.c4.ctg.1	958	13.4	0	.	p	.	0	H17Y	NONSYN	49	51	CAT	104	106	TAT	2;2;2	T;A;T	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	238	gadW	729	729	94.24	gadW.l6.c4.ctg.1	958	13.4	0	.	p	.	0	Q21H	NONSYN	61	63	CAA	116	118	CAT	3;3;3	C;A;T	3;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	238	gadW	729	729	94.24	gadW.l6.c4.ctg.1	958	13.4	0	.	p	.	0	L31V	NONSYN	91	93	CTG	146	148	GTG	2;2;2	G;T;G	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	238	gadW	729	729	94.24	gadW.l6.c4.ctg.1	958	13.4	0	.	p	.	0	D34E	NONSYN	100	102	GAT	155	157	GAG	2;2;2	G;A;G	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	238	gadW	729	729	94.24	gadW.l6.c4.ctg.1	958	13.4	0	.	p	.	0	L46P	NONSYN	136	138	CTG	191	193	CCG	2;2;2	C;C;G	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	238	gadW	729	729	94.24	gadW.l6.c4.ctg.1	958	13.4	0	.	p	.	0	E54D	NONSYN	160	162	GAA	215	217	GAT	7;9;9	G;A;T	7;9;9	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	238	gadW	729	729	94.24	gadW.l6.c4.ctg.1	958	13.4	0	.	p	.	0	I88M	NONSYN	262	264	ATA	317	319	ATG	9;9;9	A;T;G	9;9;9	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	238	gadW	729	729	94.24	gadW.l6.c4.ctg.1	958	13.4	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	320	322	CCG	8;8;8	C;C;G	8;8;8	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	238	gadW	729	729	94.24	gadW.l6.c4.ctg.1	958	13.4	0	.	p	.	0	D100E	NONSYN	298	300	GAC	353	355	GAA	4;4;4	G;A;A	3;3;4	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	238	gadW	729	729	94.24	gadW.l6.c4.ctg.1	958	13.4	0	.	p	.	0	P101S	NONSYN	301	303	CCC	356	358	TCC	4;4;3	T;C;C	4;4;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	238	gadW	729	729	94.24	gadW.l6.c4.ctg.1	958	13.4	0	.	p	.	0	R102G	NONSYN	304	306	CGG	359	361	GGG	3;4;4	G;G;G	3;4;4	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	238	gadW	729	729	94.24	gadW.l6.c4.ctg.1	958	13.4	0	.	p	.	0	K110N	NONSYN	328	330	AAA	383	385	AAT	4;4;5	A;A;T	4;4;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	238	gadW	729	729	94.24	gadW.l6.c4.ctg.1	958	13.4	0	.	p	.	0	S234A	NONSYN	700	702	TCG	755	757	GCG	27;26;27	G;C;G	26;26;27	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	988	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1369	38.6	0	.	p	.	0	F53L	NONSYN	157	159	TTC	445	447	TTA	41;41;38	T;T;A	41;39;38	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	988	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1369	38.6	0	.	p	.	0	V79I	NONSYN	235	237	GTT	523	525	ATT	47;46;45	A;T;T	46;45;45	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	988	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1369	38.6	0	.	p	.	0	R246G	NONSYN	736	738	AGA	1024	1026	GGA	45;46;47	G;G;A	45;46;46	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	988	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1369	38.6	0	.	p	.	0	S248P	NONSYN	742	744	TCG	1030	1032	CCG	39;33;34	C;C;G	38;32;34	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	4080	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3258	67.3	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2363	2365	GAA	70;69;71	G;A;A	70;69;70	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	4080	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3258	67.3	1	SNP	p	S83I	0	.	.	247	249	TCG	578	580	TCG	75;68;64	T;C;G	74;68;64	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	4080	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3258	67.3	1	SNP	p	S83W	0	.	.	247	249	TCG	578	580	TCG	75;68;64	T;C;G	74;68;64	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	4080	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3258	67.3	1	SNP	p	S83L	0	.	.	247	249	TCG	578	580	TCG	75;68;64	T;C;G	74;68;64	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	4080	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3258	67.3	1	SNP	p	D87H	0	.	.	259	261	GAC	590	592	GAC	67;69;70	G;A;C	66;69;69	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	4080	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3258	67.3	1	SNP	p	D87G	0	.	.	259	261	GAC	590	592	GAC	67;69;70	G;A;C	66;69;69	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	4080	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3258	67.3	1	SNP	p	D87V	0	.	.	259	261	GAC	590	592	GAC	67;69;70	G;A;C	66;69;69	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	4080	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3258	67.3	1	SNP	p	D87N	0	.	.	259	261	GAC	590	592	GAC	67;69;70	G;A;C	66;69;69	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	4080	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3258	67.3	1	SNP	p	D87Y	0	.	.	259	261	GAC	590	592	GAC	67;69;70	G;A;C	66;69;69	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	523	3794	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3041	67.1	1	SNP	p	R136E	0	.	.	406	408	CGC	698	700	CGC	73;69;70	C;G;C	72;69;70	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	523	3794	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3041	67.1	1	SNP	p	R136L	0	.	.	406	408	CGC	698	700	CGC	73;69;70	C;G;C	72;69;70	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	523	3794	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3041	67.1	1	SNP	p	R136C	0	.	.	406	408	CGC	698	700	CGC	73;69;70	C;G;C	72;69;70	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	523	3794	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3041	67.1	1	SNP	p	R136I	0	.	.	406	408	CGC	698	700	CGC	73;69;70	C;G;C	72;69;70	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	523	3794	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3041	67.1	1	SNP	p	R136G	0	.	.	406	408	CGC	698	700	CGC	73;69;70	C;G;C	72;69;70	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	523	3794	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3041	67.1	1	SNP	p	R136H	0	.	.	406	408	CGC	698	700	CGC	73;69;70	C;G;C	72;69;70	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	523	3794	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3041	67.1	1	SNP	p	R136S	0	.	.	406	408	CGC	698	700	CGC	73;69;70	C;G;C	72;69;70	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	523	3794	gyrB_1	2415	69	98.55	gyrB_1.l15.c4.ctg.2	69	0.0	0	.	p	.	0	T392P	NONSYN	1174	1176	ACC	37	39	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	934	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1177	42.4	0	.	p	.	0	A72P	NONSYN	214	216	GCG	513	515	CCG	52;54;55	C,T;C;G	51,1;54;55	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	934	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1177	42.4	0	.	p	.	0	T123A	NONSYN	367	369	ACC	666	668	GCC	39;41;41	G;C;C	38;40;41	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	1450	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1450	53.8	0	.	p	.	0	P9S	NONSYN	25	27	CCA	280	282	TCA	36;40;41	T;C;A	35;40;41	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	596	marA	384	384	99.74	marA.l15.c4.ctg.1	904	35.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	364	marR	435	435	97.7	marR.l15.c17.ctg.1	748	25.7	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	491	493	AGC	32;30;28	A;G;C	31;30;28	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	364	marR	435	435	97.7	marR.l15.c17.ctg.1	748	25.7	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	593	595	CAT	10;7;7	C;A;T	9;4;7	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	364	marR	435	435	97.7	marR.l15.c17.ctg.1	748	25.7	1	SNP	p	V45E	0	.	.	133	135	GTG	317	319	GTG	60;60;58	G;T;G	60;60;58	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	364	marR	435	435	97.7	marR.l15.c17.ctg.1	748	25.7	1	SNP	p	I49S	0	.	.	145	147	ATC	329	331	ATC	56;54;50	A;T;C	56;53;50	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	364	marR	435	435	97.7	marR.l15.c17.ctg.1	748	25.7	1	SNP	p	A70T	0	.	.	208	210	GCA	392	394	GCA	33;33;33	G;C;A	33;33;33	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	364	marR	435	435	97.7	marR.l15.c17.ctg.1	748	25.7	1	SNP	p	R73C	0	.	.	217	219	CGT	401	403	CGT	32;31;30	C;G;T	32;31;30	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	364	marR	435	435	97.7	marR.l15.c17.ctg.1	748	25.7	1	SNP	p	R73S	0	.	.	217	219	CGT	401	403	CGT	32;31;30	C;G;T	32;31;30	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	364	marR	435	435	97.7	marR.l15.c17.ctg.1	748	25.7	1	SNP	p	R77L	0	.	.	229	231	CGC	413	415	CGC	33;33;34	C;G;C	33;33;34	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	364	marR	435	435	97.7	marR.l15.c17.ctg.1	748	25.7	1	SNP	p	R77C	0	.	.	229	231	CGC	413	415	CGC	33;33;34	C;G;C	33;33;34	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	364	marR	435	435	97.7	marR.l15.c17.ctg.1	748	25.7	1	SNP	p	L78M	0	.	.	232	234	CTG	416	418	CTG	34;34;33	C;T;G	34;34;33	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	364	marR	435	435	97.7	marR.l15.c17.ctg.1	748	25.7	1	SNP	p	R94H	0	.	.	280	282	CGC	464	466	CGC	30;30;31	C;G;C	30;30;31	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	364	marR	435	435	97.7	marR.l15.c17.ctg.1	748	25.7	1	SNP	p	R94S	0	.	.	280	282	CGC	464	466	CGC	30;30;31	C;G;C	30;30;31	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	364	marR	435	435	97.7	marR.l15.c17.ctg.1	748	25.7	1	SNP	p	V96E	0	.	.	286	288	GTA	470	472	GTA	30;30;31	G;T;A	29;30;31	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1360	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1744	41.9	0	.	p	.	0	S7F	NONSYN	19	21	TCC	215	217	TTC	14;14;14	T;T;C	14;14;14	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1360	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1744	41.9	0	.	p	.	0	R36I	NONSYN	106	108	AGG	302	304	ATC	29;30;30	A;T;C	29;29;30	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1360	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1744	41.9	0	.	p	.	0	E42A	NONSYN	124	126	GAA	320	322	GCC	19;21;20	G;C;C	19;21;20	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1360	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1744	41.9	0	.	p	.	0	N43V	NONSYN	127	129	AAT	323	325	GTG	20;20;21	G;T;G	20;20;21	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1360	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1744	41.9	0	.	p	.	0	E52D	NONSYN	154	156	GAG	350	352	GAT	32;31;31	G;A;T	32;30;31	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1360	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1744	41.9	0	.	p	.	0	N59T	NONSYN	175	177	AAC	371	373	ACC	35;34;34	A;C;C	35;34;33	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1360	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1744	41.9	0	.	p	.	0	I68L	NONSYN	202	204	ATA	398	400	TTA	27;27;26	T;T;A	27;27;26	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1360	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1744	41.9	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	539	541	CAG	78;79;78	C;A;G	77;79;78	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1360	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1744	41.9	0	.	p	.	0	D128A	NONSYN	382	384	GAC	578	580	GCC	53;53;54	G;C;C	53;53;54	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1360	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1744	41.9	0	.	p	.	0	S163A	NONSYN	487	489	TCG	683	685	GCG	52;53;54	G;C;G	52;52;53	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1360	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1744	41.9	0	.	p	.	0	L231V	NONSYN	691	693	CTT	887	889	GTT	40;42;43	G;T;T	36;38;37	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1360	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1744	41.9	0	.	p	.	0	R285fs	FSHIFT	853	853	C	1049	1049	C	50	C	50	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1330	mdtA	1248	1248	97.36	mdtA.l6.c30.ctg.1	1724	41.5	0	.	p	.	0	V12trunc	TRUNC	34	34	G	274	274	G	54	G	54	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1330	mdtA	1248	1248	97.36	mdtA.l6.c30.ctg.1	1724	41.5	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	331	333	CAG	33;35;36	C;A;G	32;34;36	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1330	mdtA	1248	1248	97.36	mdtA.l6.c30.ctg.1	1724	41.5	0	.	p	.	0	T83I	NONSYN	247	249	ACC	481	483	ATC	50;48;45	A;T;C	49;46;45	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1330	mdtA	1248	1248	97.36	mdtA.l6.c30.ctg.1	1724	41.5	0	.	p	.	0	I99M	NONSYN	295	297	ATA	529	531	ATG	27;28;28	A;T;G	26;28;28	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1330	mdtA	1248	1248	97.36	mdtA.l6.c30.ctg.1	1724	41.5	0	.	p	.	0	A130T	NONSYN	388	390	GCC	622	624	ACC	39;38;35	A;C;C	39;38;35	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1330	mdtA	1248	1248	97.36	mdtA.l6.c30.ctg.1	1724	41.5	0	.	p	.	0	P257T	NONSYN	769	771	CCG	1003	1005	ACG	49;52;53	A;C;G	49;50;53	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	4150	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3728	59.9	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2039	2041	ACC	84;81;81	A;C;C	84;81;81	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	4150	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3728	59.9	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2432	2434	CAA	49;50;51	C;A;A	48;50;49	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	4150	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3728	59.9	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2600	2602	ATT	48;49;50	A;T;T	48;49;50	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	4150	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3728	59.9	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2684	2686	GTT	45;45;45	G;T;T	45;44;44	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	4150	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3728	59.9	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2792	2794	GAG	52;53;48	G;A;G	51;53;47	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	4150	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3728	59.9	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	3020	3022	ATG	58;60;59	A;T;G	57;60;59	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	4150	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3728	59.9	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3155	3157	GAT	57;56;59	G;A;T	57;56;58	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	3942	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3557	59.6	0	.	p	.	0	I46M	NONSYN	136	138	ATC	360	362	ATG	30;30;30	A;T;G	30;30;30	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	3942	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3557	59.6	0	.	p	.	0	V208I	NONSYN	622	624	GTC	846	848	ATC	74;73;73	A;T;C	73;72;73	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	3942	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3557	59.6	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3162	3164	CAC	20;20;20	C;A;C	19;20;20	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	3942	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3557	59.6	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3165	3167	CTC	21;20;19	C;T;C	21;19;18	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1750	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	2138	44.0	0	.	p	.	0	D3E	NONSYN	7	9	GAT	384	386	GAA	39;39;40	G;A;A	38;39;40	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1750	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	2138	44.0	0	.	p	.	0	T226A	NONSYN	676	678	ACG	1053	1055	GCG	60;59;60	G;C;G	60;59;60	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1750	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	2138	44.0	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1395	1397	ATC	51;49;51	A;T;C	51;49;51	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1750	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	2138	44.0	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1698	1700	TTT	81;82;80	T;T;T	81;82;80	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1968	mdtE	1158	1158	99.31	mdtE.l6.c30.ctg.1	1759	60.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	4836	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3723	69.9	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1189	1191	ACC	78;80;80	A;C;C	77;77;80	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	4836	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3723	69.9	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2431	2433	GAC	98;96;95	G;A;C	96;95;93	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1778	mdtG	1227	1047	99.33	mdtG.l15.c30.ctg.1	1680	47.7	0	.	p	.	0	V200I	NONSYN	598	600	GTC	692	694	ATC	68;68;66	A;T;C	68;67;66	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1778	mdtG	1227	182	99.45	mdtG.l15.c30.ctg.2	556	25.7	0	.	p	.	0	E5G	NONSYN	13	15	GAA	122	124	GGA	28;29;30	G;G;A	28;29;30	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1564	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1681	49.8	0	.	p	.	0	G134C	NONSYN	400	402	GGT	672	674	TGT	56;55;54	T;G;T	56;55;54	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1564	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1681	49.8	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1242	1244	TTG	55;56;55	T;T;G	55;56;55	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1564	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1681	49.8	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1452	1454	ACG	18;20;20	A;C;G	17;19;18	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1728	mdtL	1176	1176	98.38	mdtL.l15.c4.ctg.1	1785	52.0	0	.	p	.	0	A185S	NONSYN	553	555	GCC	857	859	TCC	52;53;53	T,C;C;C	47,1;52;53	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	1402	mdtN	1032	1032	98.06	mdtN.l6.c30.ctg.1	1592	47.2	0	.	p	.	0	V119I	NONSYN	355	357	GTT	628	630	ATT	55;55;56	A;T;T	55;55;55	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2960	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2419	65.1	0	.	p	.	0	V11M	NONSYN	31	33	GTG	201	203	ATG	41;43;44	A;T;G	41;43;44	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2960	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2419	65.1	0	.	p	.	0	T33I	NONSYN	97	99	ACC	267	269	ATC	36;36;37	A;T,G;C	33;35,1;37	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2960	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2419	65.1	0	.	p	.	0	C116R	NONSYN	346	348	TGC	516	518	CGC	76;74;75	C;G;C	76;74;75	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2960	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2419	65.1	0	.	p	.	0	N238S	NONSYN	712	714	AAC	882	884	AGC	55;53;55	A;G;C	55;53;55	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2960	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2419	65.1	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1083	1085	GTG	54;54;57	G;T;G,A	54;52;56,1	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2960	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2419	65.1	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1146	1148	AAC	36;37;38	A;A;C	35;34;36	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2960	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2419	65.1	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1191	1193	GTC	60;61;63	G;T;C	59;60;62	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2960	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2419	65.1	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1221	1223	ATA	75;73;73	A;T;A	75;73;73	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2960	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2419	65.1	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1329	1331	TCT	61;65;63	T;C;T	61;65;63	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2960	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2419	65.1	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1716	1718	GCG	60;63;67	G;C;G	58;61;67	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2960	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2419	65.1	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1929	1931	ATC	79;78;76	A;T;C	78;78;76	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	2006	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2063	52.3	0	.	p	.	0	S129A	NONSYN	385	387	TCA	706	708	GCG	63;66;65	G;C;G	63;65;65	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	2006	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2063	52.3	0	.	p	.	0	A187T	NONSYN	559	561	GCC	880	882	ACC	72;74;76	A;C;C	72;74;76	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	2006	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2063	52.3	0	.	p	.	0	H211R	NONSYN	631	633	CAC	952	954	CGC	78;77;79	C;G;C	78;77;79	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	2006	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2063	52.3	0	.	p	.	0	V250A	NONSYN	748	750	GTT	1069	1071	GCT	69;70;74	G;C;T	68;70;74	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	2006	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2063	52.3	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1153	1155	AAA	40;38;38	A;A;A	40;38;38	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	2006	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2063	52.3	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1171	1173	CGA	42;40;40	C;G;A	42;40;40	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	2006	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2063	52.3	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1336	1338	GCC	57;57;58	G;C;C	56;57;58	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	2006	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2063	52.3	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1348	1350	GAT	58;58;60	G;A;T	58;58;60	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	2006	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2063	52.3	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1765	1767	GCT	32;32;31	G;C;T	32;31;28	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	4702	mfd	3447	3447	99.16	mfd.l6.c30.ctg.1	4013	62.9	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1609	1611	AAG	51;52;51	A;A;G	51;52;51	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	4702	mfd	3447	3447	99.16	mfd.l6.c30.ctg.1	4013	62.9	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2686	2688	CTG	67;68;66	C;T;G	67;68;66	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	280	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	856	17.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2490	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2365	56.6	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1139	1141	AAC	54;53;53	A;A;C	54;52;53	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2490	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2365	56.6	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1685	1687	ATA	74;77;76	A;T;A	73;77;76	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	2084	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1729	64.7	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1336	1338	GAT	89;85;87	G;A;T	88;84;86	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	2084	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1729	64.7	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1339	1341	CTG	87;88;85	C;T,G;G	87;87,1;84	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1068	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1309	43.5	0	.	p	.	0	R27C	NONSYN	79	81	CGT	307	309	TGT	48;47;48	T;G;T	48;47;48	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1068	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1309	43.5	0	.	p	.	0	I117T	NONSYN	349	351	ATC	577	579	ACC	70;69;66	A;C;C	68;68;66	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1068	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1309	43.5	0	.	p	.	0	G187D	NONSYN	559	561	GGC	787	789	GAC	73;70;70	G;A;C	72;69;70	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1068	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1309	43.5	1	SNP	p	R15C	0	.	.	43	45	CGC	271	273	CGC	73;71;71	C;G;C	73;71;71	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1068	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1309	43.5	1	SNP	p	S33R	0	.	.	97	99	AGC	325	327	AGC	49;48;47	A;G;C	49;46;47	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1068	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1309	43.5	1	SNP	p	G131D	0	.	.	391	393	GGC	619	621	GGC	69;66;66	G;G;C	68;65;63	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1068	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1309	43.5	1	SNP	p	R203L	0	.	.	607	609	CGT	835	837	CGT	63;62;63	C;G;T	62;61;63	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1068	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1309	43.5	1	SNP	p	R203C	0	.	.	607	609	CGT	835	837	CGT	63;62;63	C;G;T	62;61;63	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1838	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1586	62.1	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1187	1189	GAG	78;79;81	G;A;G,T	78;79;80,1	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1838	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1586	62.1	1	SNP	p	G141D	0	.	.	421	423	GGT	674	676	GGT	103;102;102	G;G;T	103;102;102	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1838	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1586	62.1	1	SNP	p	G141E	0	.	.	421	423	GGT	674	676	GGT	103;102;102	G;G;T	103;102;102	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1838	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1586	62.1	1	SNP	p	R154D	0	.	.	460	462	CGT	713	715	CGT	96;94;95	C;G;T	96;94;95	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1838	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1586	62.1	1	SNP	p	R154A	0	.	.	460	462	CGT	713	715	CGT	96;94;95	C;G;T	96;94;95	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3792	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2716	74.8	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1846	1848	GTG	87;85;81	G;T;G	87;84;81	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3792	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2716	74.8	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1873	1875	TCG	94;92;97	T;C;G	83;86;93	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3792	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2716	74.8	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2488	2490	AAC	50;51;50	A;A;C	50;51;50	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3792	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2716	74.8	1	SNP	p	A85T	0	.	.	253	255	GCG	502	504	GCG	87;89;90	G;C;G	83;87;89	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3792	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2716	74.8	1	SNP	p	D111H	0	.	.	331	333	GAT	580	582	GAT	82;84;84	G;A;T	82;84;84	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3792	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2716	74.8	1	SNP	p	S129P	0	.	.	385	387	TCC	634	636	TCC	77;73;74	T;C;C	76;73;74	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	2200	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2497	47.3	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1722	1724	AAC	66;68;67	A;A;C	66;67;66	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	2200	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2497	47.3	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1731	1733	GAT	75;75;75	G;A;T	74;74;75	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	2356	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1929	65.5	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	879	881	CAG	100;101;100	C;A;G	100;101;100	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	2356	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1929	65.5	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1353	1355	GAT	85;86;87	G;A;T	85;86;87	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	7138	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4472	85.7	1	SNP	p	V146F	0	.	.	436	438	GTT	692	694	GTT	80;80;77	G;T;T	78;79;76	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	7138	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4472	85.7	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1793	1795	CAG	97;97;97	C;A;G	96;93;96	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	7138	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4472	85.7	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1793	1795	CAG	97;97;97	C;A;G	96;93;96	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	7138	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4472	85.7	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1832	1834	CAC	88;89;86	C;A;C	88;89;86	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	7138	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4472	85.7	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1841	1843	CGT	85;85;85	C;G;T	85;85;85	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	7138	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4472	85.7	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1841	1843	CGT	85;85;85	C;G;T	85;85;85	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	7138	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4472	85.7	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1847	1849	TCC	84;85;83	T;C;C	84;85;83	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	7138	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4472	85.7	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1853	1855	CTC	86;84;83	C;T;C	86;84;83	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	7138	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4472	85.7	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1943	1945	ACC	93;92;95	A;C;C	93;92;95	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	7138	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4472	85.7	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1946	1948	CCT	94;93;93	C;C;T	94;93;90	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	7138	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4472	85.7	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2315	2317	CGT	125;121;114	C;G;T	125;121;114	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	19562	rrsB+	1542	519	100.0	rrsB+.l15.c30.ctg.2	533	604.2	1	SNP	n	A1519G	0	.	.	1519	1519	A	496	496	A	403	A	394	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	19562	rrsB+	1542	519	100.0	rrsB+.l15.c30.ctg.2	533	604.2	1	SNP	n	A1519C	0	.	.	1519	1519	A	496	496	A	403	A	394	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	19562	rrsB+	1542	519	100.0	rrsB+.l15.c30.ctg.2	533	604.2	1	SNP	n	A1519T	0	.	.	1519	1519	A	496	496	A	403	A	394	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	19562	rrsB+	1542	519	100.0	rrsB+.l15.c30.ctg.2	533	604.2	0	HET	.	.	.	C1038T	.	1038	1038	C	15	15	C	533	C,T	172,120	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	19562	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1091	585.4	0	.	n	.	0	A226G	SNP	226	226	A	316	316	G	668	G	666	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	19562	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1091	585.4	0	.	n	.	0	C719T	SNP	719	719	C	809	809	T	514	T,C	230,280	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	19562	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1091	585.4	1	SNP	n	A794T	0	.	.	794	794	A	884	884	A	577	A,C,G	565,1,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	19562	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1091	585.4	1	SNP	n	A794G	0	.	.	794	794	A	884	884	A	577	A,C,G	565,1,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	19562	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1091	585.4	1	SNP	n	G926A	0	.	.	926	926	G	1016	1016	G	614	G	612	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	19562	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1091	585.4	1	SNP	n	G926T	0	.	.	926	926	G	1016	1016	G	614	G	612	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	19562	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1091	585.4	1	SNP	n	G926C	0	.	.	926	926	G	1016	1016	G	614	G	612	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	19562	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1091	585.4	0	HET	.	.	.	A79G	.	79	79	A	169	169	A	537	A,G	380,151	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	19562	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1091	585.4	0	HET	.	.	.	T273A	.	273	273	T	363	363	T	596	T,A	445,143	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	19562	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1091	585.4	0	HET	.	.	.	G211T	.	211	211	G	301	301	G	657	G,T	578,77	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	19562	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1091	585.4	0	HET	.	.	.	C183T,A	.	183	183	C	273	273	C	635	C,T,A	426,202,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	19562	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1091	585.4	0	HET	.	.	.	A250T,C	.	250	250	A	340	340	A	600	A,T,C	451,143,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	19562	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1091	585.4	0	HET	.	.	.	T90C,A	.	90	90	T	180	180	T	539	T,C,A	387,147,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	19562	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1091	585.4	0	HET	.	.	.	G474A	.	474	474	G	564	564	G	621	G,A	469,149	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	19562	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1091	585.4	0	HET	.	.	.	A253T	.	253	253	A	343	343	A	602	A,T	456,144	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	19562	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1091	585.4	0	HET	.	.	.	G895A	.	895	895	G	985	985	G	525	G,A	454,70	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	19562	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1091	585.4	0	HET	.	.	.	C194T	.	194	194	C	284	284	C	653	C,T	500,145	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	1096	sat_1	525	525	100.0	sat_1.l15.c4.ctg.1	1078	54.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1;sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	936	soxR	465	465	100.0	soxR.l15.c4.ctg.1	1050	47.9	1	SNP	p	R20H	0	.	.	58	60	CGC	358	360	CGC	86;89;91	C;G;C	86;89;90	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	936	soxR	465	465	100.0	soxR.l15.c4.ctg.1	1050	47.9	1	SNP	p	G121D	0	.	.	361	363	GGT	661	663	GGT	70;71;73	G;G;T	70;71;73	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	684	soxS_1	324	324	99.69	soxS_1.l6.c30.ctg.1	928	39.6	1	SNP	p	A12S	0	.	.	34	36	GCA	343	345	GCA	88;87;87	G;C;A	88;87;87	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	27	5120	APH_3____Ib+	804	804	100.0	APH_3____Ib+.l15.c4.ctg.1	1351	203.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	27	5182	APH_6__Id+	837	837	100.0	APH_6__Id+.l6.c30.ctg.1	1447	191.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.3000412.AY055428.20268_21084.552	sul2.3000412.AY055428.20268_21084.552	1	0	27	3868	sul2	816	816	100.0	sul2.l15.c30.ctg.1	1503	138.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sul2;Sul2 is a sulfonamide resistant dihydropteroate synthase of Gram-negative bacteria, usually found on small plasmids.
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	27	5712	tetA	1200	1200	100.0	tetA.l6.c30.ctg.1	1897	161.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	27	3424	tetR	651	651	100.0	tetR.l15.c4.ctg.1	1176	156.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	2362	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	2136	59.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
